HomeCompareSYK vs ORAN

SYK vs ORAN: Dividend Comparison 2026

SYK yields 1.04% · ORAN yields 7.00%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SYK wins by $9.1K in total portfolio value· pulled ahead in Year 9
10 years
SYK
SYK
● Live price
1.04%
Share price
$326.10
Annual div
$3.40
5Y div CAGR
46.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$43.3K
Annual income
$8,282.98
Full SYK calculator →
ORAN
ORAN
● Live price
7.00%
Share price
$11.15
Annual div
$0.78
5Y div CAGR
2.9%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$1,544.09
Full ORAN calculator →

Portfolio growth — SYK vs ORAN

📍 SYK pulled ahead of the other in Year 9

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSYKORAN
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SYK + ORAN cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SYK pays
ORAN pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SYK
Annual income on $10K today (after 15% tax)
$88.62/yr
After 10yr DRIP, annual income (after tax)
$7,040.53/yr
ORAN
Annual income on $10K today (after 15% tax)
$594.62/yr
After 10yr DRIP, annual income (after tax)
$1,312.48/yr
At 15% tax rate, SYK beats the other by $5,728.06/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SYK + ORAN for your $10,000?

SYK: 50%ORAN: 50%
100% ORAN50/50100% SYK
Portfolio after 10yr
$38.7K
Annual income
$4,913.54/yr
Blended yield
12.68%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SYK right now

SYK
Analyst Ratings
1
Strong
35
Buy
14
Hold
Consensus: Buy
Price Target
$428.67
+31.5% upside vs current
Range: $390.00 — $469.00
Altman Z
4.0
Piotroski
5/9
ORAN
Analyst Ratings
5
Buy
8
Hold
1
Sell
Consensus: Hold
Price Target
$13.00
+16.6% upside vs current
Range: $13.00 — $13.00
Altman Z
1.3
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SYK buys
0
ORAN buys
0
No recent congressional trades found for SYK or ORAN in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSYKORAN
Forward yield1.04%7.00%
Annual dividend / share$3.40$0.78
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR46.2%2.9%
Portfolio after 10y$43.3K$34.2K
Annual income after 10y$8,282.98$1,544.09
Total dividends collected$21.0K$11.0K
Payment frequencyquarterlyquarterly
SectorHealthcareStock
Analyst consensusBuyHold
Analyst price target$428.67$13.00

Year-by-year: SYK vs ORAN ($10,000, DRIP)

YearSYK PortfolioSYK Income/yrORAN PortfolioORAN Income/yrGap
1$10,852$152.43$11,420$719.84$568.00ORAN
2$11,838$226.03$13,010$790.55$1.2KORAN
3$13,004$336.89$14,787$866.10$1.8KORAN
4$14,420$505.63$16,768$946.67$2.3KORAN
5$16,195$766.09$18,974$1,032.40$2.8KORAN
6$18,504$1,175.64$21,426$1,123.47$2.9KORAN
7$21,635$1,835.40$24,146$1,220.03$2.5KORAN
8$26,082$2,932.10$27,158$1,322.21$1.1KORAN
9← crossover$32,737$4,829.68$30,490$1,430.19+$2.2KSYK
10$43,312$8,282.98$34,168$1,544.09+$9.1KSYK

SYK vs ORAN: Complete Analysis 2026

SYKHealthcare

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.

Full SYK Calculator →

ORANStock

Orange S.A. provides various fixed telephony and mobile telecommunications, data transmission, and other value-added services to customers, businesses, and other telecommunications operators in France and internationally. It operates through France; Spain and Other European Countries; The Africa and Middle East; Enterprise; International Carriers & Shared Services; and Mobile Financial Services segments. The company offers mobile services, such as voice, SMS, and data; fixed broadband and narrowband services, as well as fixed network business solutions, including voice and data; and convergence packages. It also sells mobile handsets, mobile terminals, broadband equipment, connected devices, and accessories. In addition, the company provides IT and integration services comprising unified communication and collaboration services, such as LAN and telephony, consultancy, integration, and project management; hosting and infrastructure services, including cloud computing; customer relations management and other applications services; security services; and video conferencing, as well as sells related equipment. Further, it offers national and international roaming services; online advertising services; and mobile virtual network operators, network sharing, and mobile financial services, as well as sells equipment to external distributors and brokers. Orange S.A. markets its products and services under the Orange brand. The company was formerly known as France Telecom and changed its name to Orange S.A. in July 2013. Orange S.A. was founded in 1990 and is headquartered in Issy-les-Moulineaux, France.

Full ORAN Calculator →
📬

Get this SYK vs ORAN comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SYK vs SCHDSYK vs JEPISYK vs OSYK vs KOSYK vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.